Login / Signup

Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017-2018.

Chintal H ShahRobert M ReedLinda WastilaEberechukwu OnukwughaMathangi GopalakrishnanZafar Zafari
Published in: Applied health economics and health policy (2023)
COPD poses a significant economic burden on healthcare payers and patients 45 years of age and older in the USA. While prescription drugs accounted for almost half of the total cost, more than 10% of the prescription drug cost was out-of-pocket.
Keyphrases